IL-33, ST2, and ILC Pathways

Özet henüz yok.

• UMUT CAN KÜÇÜKSEZER

Özet henüz yok.

• AHMET KÜRŞAT AZKUR

1584

• GÜNNUR DENİZ

Özet henüz yok.

• ZEYNEP ÇELEBİ SÖZENER

PURPOSE: Acute myocardial infarction (AMI) is the most common cause of death in the world. Comprehensive risk assessment of patients presenting with chest pain and eliminating undesirable results should decrease morbidity and mortality rates, increase the quality of life of patients, and decrease health expenditure in…

• MELTEM YARDIM

PURPOSE: Acute myocardial infarction (AMI) is the most common cause of death in the world. Comprehensive risk assessment of patients presenting with chest pain and eliminating undesirable results should decrease morbidity and mortality rates, increase the quality of life of patients, and decrease health expenditure in…

• İBRAHİM ŞAHİN

Özet henüz yok.

• ZEYNEP ÇELEBİ SÖZENER

Özet henüz yok.

• GÖKÇE AŞKAN

Significant advancements have been made in understanding the cellular and molecular mechanisms of type 2 immunity in allergic diseases such as asthma, allergic rhinitis, chronic rhinosinusitis, eosinophilic esophagitis (EoE), food and drug allergies, and atopic dermatitis (AD). Type 2 immunity has evolved to protect a…

• ÖZGE ARDIÇLI

Significant advancements have been made in understanding the cellular and molecular mechanisms of type 2 immunity in allergic diseases such as asthma, allergic rhinitis, chronic rhinosinusitis, eosinophilic esophagitis (EoE), food and drug allergies, and atopic dermatitis (AD). Type 2 immunity has evolved to protect a…

• SENA ARDIÇLI

Özet henüz yok.

• ALİ DÜZOVA

Significant advancements have been made in understanding the cellular and molecular mechanisms of type 2 immunity in allergic diseases such as asthma, allergic rhinitis, chronic rhinosinusitis, eosinophilic esophagitis (EoE), food and drug allergies, and atopic dermatitis (AD). Type 2 immunity has evolved to protect a…